The European Investment Bank (EIB) and GeNeuro, a French biopharmaceutical company, has entered through its R&D subsidiary, GeNeuro Innovation, into a financing agreement for a total amount of up to EUR 25 million. The
The European Investment Bank (EIB) and GeNeuro, a French biopharmaceutical company, has entered through its R&D subsidiary, GeNeuro Innovation, into a financing agreement for a total amount of up to EUR 25 million. The